#polyomavirus

#polyomavirus

By day, virologist Chris Buck works for the National Cancer Institute (NCI) in Maryland, where he's discovered four of the 13 polyomaviruses we know to affect humans, Science News reports. But by night, he runs Gusteau Research Corporation, a one-man shell company he established so he could experiment on his bubbly inoculation: an ingestible polyomavirus vaccine. To make the beer, Buck engineered a special strain of yeast infused with polyomavirus-like particles.